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Str. bovis  Streptococcus bovis 
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SUAM  surface adhesion molecule  
tmRNA  transfer-messenger RNA 
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INTRODUCTION 
Mastitis, mostly caused by bacterial infection of the mammary gland, is a major 
health problem of dairy cows. The resulting decrease of milk production and 
reduction of its quality along with medication costs and probable premature 
culling of animals cause essential economic burden. The total mastitis caused 
losses in dairy industry are estimated to be 16–26 billion € annually in view of a 
global population of 271 million dairy cows [1]. It has been estimated, that 
about 1/3 of all dairy cows are suffering from mastitis at least once per year [2].  
Mastitis is a dynamic disease and has different forms. Clinical mastitis is 
easily detected by visible abnormalities of milk and external symptoms. The 
diagnostics of subclinical infections is more problematic as there are no 
detectable signs besides the changed characteristics of milk.  
For the identification of mastitis-causing pathogens, the gold standard is 
microbiological culturing of bacteria, which in recent years has been partially 
replaced by polymerase chain reaction analyses of bacterial DNA. Although 
reliable, these methods require hours to obtain results, not allowing effective 
treatment of animals and optimal milk processing. Therefore, to assure timely 
and correct treatment of animals, there is a great need for a method applicable 
for rapid automatic detection of mastitis causing pathogens in milk.  
A challenging tool for on-line detection of pathogens is the application of 
biosensors. The benefits of biosensors are their high selectivity, low cost, 
simplicity and short analysis time. There have been already proposed several 
biosensors for detection of particular bacteria, while biosensing systems for 
rapid simultaneous detection of pathogens, especially the specific mastitis-
causing ones in milk matrix, are scarce. 
The main goal of the present work was to develop a rapid method for 
multiplex detection of major mastitis causing pathogens, which can be used in 
farms for automatic monitoring of raw milk. We used an immuno-biosensing 
system, based on bead injection analyses. This biosensor system allowed semi-
specific capture of bacteria onto a micro-column and consecutive specific 
detection of the attached bacteria with differently labelled secondary antibodies. 
We found the optimal conditions for both single and multiplexed pathogen 
detection and used the developed protocols for the studies of the selectivity and 
sensitivity of the biosensing system in buffer and in milk matrix. A novel 
approach for the calibration of biosensor for single pathogens was proposed and 
the characteristic parameters calculated for the detection of all studied patho-
gens (Staphylococcus aureus, Escherichia coli and Streptococcus uberis) in 
milk. In Estonia, these three pathogens are responsible for nearly 40% of all 
cases of mastitis [3]. Finally, the biosensing system was used for the detection 
of pathogens in the milk of infected cows, whereas the unknown pathogens 
were quantified both with the biosensor and microbiological cultivation. 
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1. LITERATURE OVERVIEW 
1.1. Mastitis 
Mastitis is an inflammation of the mammary gland, caused by the invasion of 
various pathogens through the teat canal, allergy or physical trauma [4]. In dairy 
industry, mastitis is one of the most costly problems. The resulting economic 
burden includes direct losses as temporary/permanent decrease in milk 
production and full rejection of milk in cases of clinical mastitis or due to the 
presence of antibiotic residues in the milk of treated animals. Mastitis also 
affects the quality and composition of milk: contents of lactose and casein are 
decreased while contents of whey protein and total protein can be increased [5–
7]. Indirect losses include increased veterinarian and medication costs, 
additional diagnostics/laboratory expenses, decreased animal sale prices and 
finally premature culling of dairy cows and their early replacement costs [5–7]. 
The total mastitis-caused losses in global dairy industry are estimated to be 16–
26 billion € per annum based on the overall dairy cow population of 271 million 
[1].  
Mastitis is the most frequent disease in dairy farms, it has been estimated 
that about 1/3 of all cows in the world are suffering from mastitis at least once 
per year [2]. Mastitis pathogens are usually bacteria and more than 150 different 
bacterial species and subspecies may be involved in the induction of bovine 
mastitis [6]. In addition molds, yeast, and prototheca can act as mastitis 
inducing agents [6]. However, in majority cases are caused by one primary 
pathogen from approximately ten bacterial species or groups of species, like 
Staphylococcus aureus (S. aureus), Escherichia coli (E. coli), Streptococcus 
uberis (Str. uberis), Streptococcus agalactiae (Str. agalactiae), Streptococcus 
dysgalactiae (Str. dysgalactiae) and Mycoplasma spp [6;8]. In Estonia, three 
major pathogens S. aureus, E. coli and Str. uberis are responsible for nearly 
40% of all cases of mastitis [3]. In Israel the proportion of mastitis caused by E. 
coli is even as high as 60% [9]. 
Bovine mastitis can be classified as contagious or environmental, depending 
of pathogens primary reservoir and how they are contracted and transferred 
between animals [10]. Contagious pathogens are usually found on the udder or 
teat surface of infected cows and are the primary sources of infection between 
uninfected and infected udder quarters, which occurs during milking. This kind 
infections are usually caused by S. aureus, Str. agalactiae, Str. dysgalactiae, 
Mycoplasma bovis and Corynebacterium bovis [11]. 
Environmental mastitis is caused by organisms such as E. coli, Str. uberis 
and Klebisella pneumoniae, which normally do not live on skin or in udder. 
These pathogens enter the teat canal when a cow comes in contact with conta-
minated environment. These bacteria are often found in faeces, bedding mate-
rials and feed [4]. The control of environmental mastitis in farms has been less 
effective than of the contagious one and therefore proportion of intramammary 
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infections caused by environmental pathogens has been increased markedly 
[12]. 
Milk of animals suffering from clinical mastitis is characterized by visible 
abnormalities like flakes, clots and a watery appearance; external symptoms of 
clinical mastitis are usually associated with udder heat, redness, swelling and 
sensitivity to touch [4]. Subclinical mastitis (SM) is a non-symptomatic form of 
intramammary inflammation. Upon one clinical case, comes new 15–40 sub-
clinical cases, making this the most frequent form of mastitis [13]. Compared to 
healthy animals, subclinically infected cows produce less milk, and the quality 
of the milk is reduced similar to clinical mastitis. In addition, infected cows can 
be a source of infection to other animals in the herd [14].  
Mastitis may often to turn chronic, so it is important to identify new cases in 
the herd in time. Early detection and identification of pathogens allows to 
accelerate decisions on treatment, thereby contributing to animal health, 
reducing the time required to recover the production of normal milk and 
reducing antibiotics use [15]. 
Clinical mastitis is easily detected by visible signs; diagnosis of SM is more 
complicated and challenging. The most common methods for the detection of 
SM are California Mastitis Test (CMT), somatic cell count (SCC) and electrical 
conductivity test [16;17]. Unfortunately any of these methods does not indicate 
the causative agent of mastitis nor allows their quantitative detection. For 
example, somatic cells including lymphocytes, macrophages, polymorpho-
nuclear and epithelial cells are part of the natural defence mechanism [18]. SCC 
threshold of 200,000 cells/ml is sometimes used to indicate the status of 
subclinical mastitis under field conditions [19], but as SCC number actually 
depends on genetic factors and feeding of animals has it just an indicative 
parameter. 
The influence of mastitis-causing pathogens and SCC on milk quality must 
be minimal, because milk should be safe for human consumption. The cut-off 
value for the acceptance of a pathogen in human food depends on its ability to 
grow in refrigerated conditions, at which psychotrophic bacteria, such as 
Listeria monocytogenes, are able to proliferate [20]. The total bacterial count in 
raw milk used in processing should be lower than 105 CFU/ml [21]. According 
to Regulation No. 71 of the Estonian Ministry of Agriculture, the specific limit 
for S. aureus in raw milk for direct marketing and raw milk products should be 
under 500 CFU/ml and 2000 CFU/ml, respectively [22]. The European 
Commission has set limits to the titters of Enterobacteriaceae in pasteurized 
milk (<10 CFU/ml), and E. coli for milk that has undergone a lower heat 
treatment than pasteurisation (<100 CFU/ml). The presence of E. coli in 
primary milk production is considered to be an indicator of faecal conta-
mination and low hygienic conditions [23].  
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1.2. Short characterization of the major mastitis 
pathogens studied 
1.2.1. Staphylococcus aureus 
Staphylococcus aureus is a Gram-positive round shaped facultative anaerobe 
(≈ 1 µm), which form grape-like microscopic clusters [24;25]. S. aureus is 
nonmotile, non-spore forming, non-moving, catalase and coagulase positive 
bacteria [24;26]. S. aureus is part of the natural micro-flora of humans, com-
monly found on skin and hair as well as in noses and throats of mammalians 
[27].  
Protein A is a 42 kDa protein originally found on the surface of S. aureus 
cell wall [28]. Practically all (∼99%) S. aureus pathogenic strains possess 
surface protein A (SpA) and therefore is this protein a typical marker for the 
identification of pathogenic S. aureus strains [29–31]. Only very few other 
bacterial species (some strains of Staphylococcus epidermidis) can produce SpA 
and only in minute amounts [30;31]. It has been estimated that at least 
1,200,000 protein molecules are represent the machinery of life in a single S. 
aureus cell in average [32]. Although the distribution of SpA changes during 
the cell life-cycle, it is proposed to cover comprises 7% of the cell wall [33]. 
SpA can serve as a characteristic target for the identification of pathogenic S. 
aureus cells in mastitis milk, as it is absent in nonpathogenic staphylococci 
(Staphylococcus carnosus, some strains of Staphylococcus xylosus and 
Staphylococcus equorum) [34;35]. Each individual SpA molecule reacts 
with mammalian immunoglobulins (IgGs), or in fact with the Fc fragment of 
IgGs, therefore can this protein used as a marker for quantitative and qualitative 
immunological techniques [36;37]. The affinity of SpA to the Fc region of 
human IgG is very high; the value of affinity constant is 108 l/mol [38]. 
S. aureus is one of the most widely spread contagious pathogens in dairy 
cattle, causing both subclinical and clinical forms of mastitis. In Estonia, it 
caused 11.7% of all registered cases of subclinical and 16.6–22.8% of clinical 
mastitis registered from 2007 to 2009 [39].  
 
 
1.2.2. Escherichia coli 
Escherichia coli is characterized as Gram-negative, chemoorganotrophic, oxidase 
negative commensal bacteria that was first described by Theodor Escherich in 
1885 [40]. E. coli is a rod-shaped bacterium with 0.5 μm in diameter and 2 μm 
in length [41;42]. Most E. coli strains are harmless and colonize gastrointestinal 
tract of humans and animals as a normal flora [43]. E. coli is regarded as 
opportunistic and environmental pathogen [44].  
In E. coli, 150 different proteins have been reported to be present in the cell 
envelope [45]. There is also the outer membrane protein A (OmpA), which aids 
the attachment and detection of the bacteria and are present at 105 copies per 
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cell [46]. This highly expressed protein is an ideal antigen for sensitive 
immunobiosensing, as each cell can potentially bind numerous detecting 
molecules. 
E. coli is one of the major causative pathogens of clinical mastitis [47]. In 
2007–2009 E. coli was causing 15.9% of clinical and 2.5% of subclinical 
mastitis in Estonia [39]. The minimal number of viable E. coli bacteria that can 
induce the disease, known as the infectious dose, fluctuates between 104 and 
108 cells, depending on the strain and the individual affected [48]. 
Clinical E. coli mastitis in cows is generally recognized as acute and its results 
are often fatal [49]. The presence of E. coli is usually connected with faecal 
contamination, a phenomenon that is exploited by public health microbiologists 
as an indicator of faecal pollution of water sources, drinking water and food 
[27]. 
 
 
1.2.3. Streptococcus uberis  
Streptococcus uberis is a Gram–positive, catalase negative bacteria belonging to 
the Streptococcaceae family. The bacterium is aerotolerant and anaerobial and 
its cells have coccoid form with diameter 0.5 to 1 μm, occurring in pairs or 
chains [50]. This pathogen has been localized in farm environment including 
straw bedding, soil, faeces and water, but also on animals lips, skin and in 
wounds, where it incurs via licking [50;51]. 
Str. uberis is one of the major environmental pathogens causing bovine 
mastitis [50]. Depending on the severity of inflammation, this pathogen can 
cause subclinical, clinical and chronic forms of udder infection [52]. Str. uberis 
has been identified as cause of clinical mastitis in 18.4% cases, while for 
subclinical mastitis its involvement was 11.8% of cases in Estonia between 
2007–2009 [39].  
Str. uberis cells express special membrane-bound proteins, known as surface 
adhesion molecule (SUAM) or lactoferrin binding protein (LBP) [53]. This 
protein is an important factor in the pathogenesis of Str. uberis caused mastitis 
as it is connected with in the adherence to and internalization of micro-
organisms into bovine mammary epithelial cells [53]. The SUAM is exposed on 
the cell surface and antibodies against this protein significantly reduce bacterial 
adherence to bovine mammary epithelial cells [54]. It has been found that 
approximately 7800 binding sites of the protein molecules are expressed on the 
membrane surface of each bacterial cell with a dissociation constant (Kd) 
1.0×10–7 M towards bovine lactoferrin [55].  
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1.3. Methods for the detection of mastitis 
causing pathogens  
Mastitis has usually detected by indication of inflammation, estimation of 
somatic cell counts, or measurement of enzymes associated with tissue damage 
(e.g. N-acetyl-beta-D-glucosaminidase and lactate dehydrogenase) in milk; and 
identification of the causative microorganisms, which usually involves culturing 
methods [17]. 
The gold standard for identification of bacteria in milk is conventional 
microbiological bacterial culturing, where the presence of particular bacteria is 
indicated by their growth on an appropriate growth medium after incubation 
[56]. Microorganisms are identified according to their phenotypic characte-
ristics as colony morphology, growth and serotyping [57]. The limit of detection 
(LOD) of microbiological method is 100 CFU/ml (there is 1 CFU per plate after 
cultivation of 0.01 ml sample) [58]. The cultivation method is quite time 
consuming and takes usually more than 48 h. Some bacteria, like Str. uberis and 
Str. parauberis cannot be clearly distingushed by biochemical assays [59]. In 
addition, false results can be obtained when mastitis is induced by bacteria 
capable of intracellular survival [15].  
The microbiological culturing is suitable to detect only viable bacterial cells. 
Bacteria in the viable but nonculturable (VBNC) state fail to grow on the 
normal culturing media where they would normally grow [60]. However, these 
VBNC bacteria are still alive and capable of causing inflammation. Optimal 
culturing conditions for each microorganisms are different depending on the 
bacterial nature [61]. 
The novel methods are connected with direct detection of mastitis-causing 
bacteria using different molecular technologies, enzyme-linked immunosorbent 
assay (ELISA), nucleic acid amplification, flow cytometry, spectrometry and 
biosensing techniques. An emerging alternative for pathogen identification is 
polymerase chain reaction (PCR) test. PCR detects DNA sequences that are 
unique to specific bacteria. PCR is highly selective and is able to detect sub-
dominant species. For the detection of six major mastitis causative pathogens a 
PCR-based assay has been proposed. The available test, directly usable for milk 
samples without any culturing steps, is specific for E. coli, S. aureus, Str. 
uberis, Str. parauberis, Str. agalactiae and Str. dysgalactiae. The LOD of the 
assay is 5×103 CFU/ml and it can be performed within 4.5 hours [62]. Lee et al. 
have developed a multiplex PCR biochip which can detect seven most common 
species of mastitis-causing pathogens like Str. bovis, Str. uberis, Str. aga-
lactiae, Str. dysgalactiae, Corynebacterium bovis, S. aureus and M. bovis in 
milk within 6 h with the LOD value of 103 CFU/ml [15]. A new Thermo 
Scientific™ PathoProof™ Complete-16 Kit identifies even 16 main mastitis 
causing bacteria or bacterial groups (including S. aureus and all major 
coagulase-negative staphylococci) [63]. Despite the fact that PCR is a reliable 
and considerably fast method, the application of PCR methods requires 
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preliminary isolation of genetic material, being not suitable for in field analysis 
[64]. In addition, the determination process can be inhibited by a wide range of 
inhibitors present in mastitis milk such as proteinases, calcium ions, lactoferrin 
(leukocytes) and hemes (in blood containing milk) [6]. It is not possible to 
discriminate between live, nonculturable and dead cells with PCR methods. 
Nucleic acid sequence based amplification (NASBA) has been used for 
pathogen analysis in food. NASBA is based on the enzymatic activity of reverse 
transcriptase that amplifies RNA templates into complementary DNA. O’Grady 
et al. introduced NASBA for the amplification of transfer-messenger RNA 
(tmRNA) for the detection of S. aureus in raw milk with detection limit of 1 
CFU/ml within 3–4 h, there was no need for any culture enrichment of the 
samples [65]. 
A promising method for rapid pathogen detection in mastitis milk is loop–
mediated isothermal amplification (LAMP), which is an alternative method of 
nucleic acid amplification in PCR. LAMP method is faster than traditional PCR 
and it does not require expensive specific equipment. Several LAMP assays 
have been described for detecting single mastitis causing pathogens such as 
S. aureus with LOD 1x102 CFU/ml in mastitis milk [66], Str. uberis with LOD 
in raw milk 2.4×104 CFU/ml [67] and M. bovis with LOD in pasteurized milk 
50 CFU/ml [68]. The detection time for each pathogen was approximately 
1 hour. In addition Kawai et al. described a LAMP test for detecting 12 main 
mastitis causing pathogen families and/or genera in milk within few hours [61]. 
Unfortunately, this particular method does not provide any quantitative results.  
Gey et al. have introduced a technique called fluorescent in situ hybridi-
zation (FISH), which utilizes oligonucleotides (labelled with some fluorophore) 
that are specific to a string target DNA/RNA. FISH has been applied for the 
detection of seven mastitis pathogens (S. aureus, Str. agalactiae, Str. uberis, 
Enterecoccus faecalis, Enterecoccus faecium, E. coli and Trueperella (Arcano-
bacterium) pyogenes) directly from milk samples. The method is capable to 
detect pathogens in real mastitis milk samples with LOD of 106 CFU/ml. 
However, the detection time is relatively long as sample pre-treatment is 
required (savinase treatment 45 min and hybridization 105 min) [69]. 
Another commonly used method for pathogen quantification is enzyme-
linked immunosorbent assay (ELISA), which is a biochemical technique 
combining an immunoassay with an enzymatic assay. ELISA is a widely used 
immunological approach that is less complicated and less expensive. It takes 
typically 3–4 h, even 6 h, while it includes several consequent incubation steps 
[70;71]. ELISA is not suitable for on-line detection. 
A promising technology for monitoring the safety of milk is flow cytometry. 
This method can provide accurate multiple bacterial counts with LOD below 
104 cells/ml in ultra-heat-treated milk within 1 h [72]. Although flow cytometry 
is a fast method, it needs additional steps to distinguish between cell types. Its 
high cost and poor signal/noise ratio in complex matrices have prevented its 
uptake by the food industry [73]. A condensed summary of currently available 
technologies for the detection of pathogens in milk is given in Table 1. 
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Table 1. Methods for detection of major mastitis causing pathogens in milk. 
Method for 
pathogen 
detection 
Pathogens Linear 
range, 
CFU/ml 
LOD, 
CFU/ml 
Time, h Ref. 
ELISA E. coli O157:H7 n. a. 102 < 6 [71] 
Flow cytometry Total bacteria count in 
milk  
n. a. < 104 1 [72] 
ELISA based 
PCR 
E. coli 1–104 102 5 [74] 
PCR Str. bovis, Str. uberis,  
Str. agalactiae,  
Str. dysgalactiae, C. bovis, 
S. aureus, M. bovis; 
Simulataneously 
103–107 103–105 6 [15] 
NASBA S. aureus n. a. 1–10 3–4 [65] 
Conventional 
microbiological 
culturing 
E. coli, S. aureus,  
Str. uberis; Separately 
n. a. 100 24–48 [58] 
LAMP S. aureus 102–106 102 < 1 [66] 
FISH S. aureus, Str. uberis, 
Str. agalactiae, 
Enterococcus faecalis, 
Enterococcus faecium, 
E. coli, Trueperella 
pyogenes; 
Simultaneously 
106–108 106 ≥ 3 [69] 
ELISA – enzyme-linked immunosorbent assay; n. a. – data not available; PCR – polymerase 
chain reaction; NASBA – nucleic acid sequence based amplification; LAMP – loop–mediated 
isothermal amplification; FISH – fluorescent in situ hybridization 
 
 
1.4. Biosensors for the pathogen detection 
A fast developing tool for pathogen detection is biosensor technology, since it is 
portable, rapid and especially suitable for conducting on- and in-line multiplex 
measurements, operating in fully automatic or manual mode [75]. Biosensors 
are devices that convert the signal of a specific biorecognition reaction into a 
measurable, e.g. electrical or optical signal. 
Biosensors are suitable for direct rapid analysis of complex samples 
requiring minimal or no sample treatment. Despite the great potential of 
biosensors, their use is still mostly limited to laboratories and only a limited 
number of biosensors for foodborne pathogens, like X-MARK (nanoRETE 
Inc.) and Aegis 1000 (BioDetection Instruments) are commercially available 
[73].  
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Different bioreceptors as antigen/antibody, enzymes, nucleic acid/DNA and 
cells have been used for the detection of bacteria in milk [76]. Currently 
available biosensing systems are typically limited for the detection of single 
pathogens, mostly S. aureus and E. coli. A selection of available biosensors for 
single pathogen detection in milk matrix is given in Table 2.  
 
Table 2. Biosensors for single pathogen detection in milk. 
Method for pathogen 
detection 
Pathogen Bio-
receptor 
Linear 
range, 
CFU/ml
LOD, 
CFU/ml
Time Ref. 
Immunomagnetic 
separation and 
colorimetric detection 
S. aureus Antibody 1.5×105–
1.5×106 
1.5x105 40 min [77] 
Amperometric 
magnetoimmunosensor 
S. aureus Antibody 4–5x104 1 2 h [78] 
Amperometric 
biosensor 
E. coli Enzyme 102 –108 102 1 h [79] 
Optical biosensor E. coli 
O157:H7 
Antibody 10–106 10 2 h [80] 
Potentiometric 
biosensor 
E. coli Aptamer-
based 
6–104 6 Few 
minutes 
[81] 
Piezoelectric quartz 
crystal microbalance 
 E. coli 
O157:H7 
Antibody 10–106 53 4 h [82] 
Semi-quantitative 
magnetic detection 
Str. uberis Antibody n. a. 102 5 h [83] 
 
Despite the increasing scientific interest and numerous biosensors, which have 
been proposed for the detection of single bacteria, biosensing systems for 
multiplex detection of pathogens, especially in milk matrix, are scarce (Table 3). 
At present, there are no biosensors, which could be used for automated 
simultaneous detection of pathogens in milk in time frame of minutes. 
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Table 3. Biosensors for multiplex pathogen detection. 
Biosensors for 
multiple pathogen 
detection 
Pathogens Bio-
receptor 
Mat-
rix 
Linear range, 
CFU/ml 
LOD, 
CFU/ml 
Time Ref. 
Chemiluminecent 
antibody array 
E. coli, 
Salmonella 
spp. 
Antibody Milk n. a. 8×104 
 
5×107 
75 min [84] 
Microfluidic 
impedance 
immunosensor  
E. coli 
O157:H7, 
S. aureus 
Antibody Milk 102–105 102 2 h [85] 
Immunomagnetic 
separation  
E. coli,  
 
Salmonella 
enteritidis 
Antibody PBS 5x102–5x105 
 
4x102–4x105 
5×102 
 
4×102 
2 h [86] 
Flowbased kinetic 
exclusion 
fluorescence 
immunoassay 
S. aureus, 
 
Pseudomo-
nas 
aeruginosa 
Antibody BSA-
PBS 
5.2x104–1.0x109
 
4.1x106–1.6x1010
 
5.2×104 
 
4.1×106 
<15 min [87] 
Glucose oxidase –
peroxidase 
composite 
amperometric 
biosensor 
E. coli,  
S. aureus, 
Salmonella 
chole-
raesuis 
Enzyme PBS 6.5–650 6.5 7 h [88] 
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2. AIMS OF THE STUDY 
The main goal of the present work was to develop a rapid method for multiplex 
detection of major mastitis causing pathogens (S. aureus, E. coli and Str. 
uberis), which can be used in farms for automatic monitoring of raw milk. This 
main goal was divided to the following objectives: 
• Design of a biosensing system for multiplex detection of bacteria. 
• Design and separation of anti-Str. uberis antibody for application in 
biosensing system. 
• Founding of optimal conditions and implementation of a protocol for the 
detection of major mastitis-causing pathogens. 
• Studying the system's sensitivity in buffer and in milk matrix.  
• Study of the system’s selectivity in the presence of different pathogens. 
• Calibration of the biosensor for the multiplex detection of all studied 
pathogens in milk matrix.  
• Validation of the biosensor results and testing the system’s applicability in 
real mastitis milk, whereas the unknown pathogens were identified and 
quantified both with the biosensor and standard microbiological cultivation 
method. 
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3. EXPERIMENTAL 
3.1. Design of a biosensor  
for multiplex detection of bacteria 
For the multiplex detection of mastitis-causing bacteria in milk an immunobio-
sensing system, based on specific antibody/antigen interaction, was proposed. 
The key aspects of the biosensor design were its selectivity, sensitivity, working 
range and applicability in complex biological sample matrix like milk.  
First, pathogens were concentrated and captured using semispecific single-
use renewable micro-columns, consisting of differently bioactivated Sephadex 
beads. The unbound sample components were removed by washing the column 
with buffer. The captured bacteria were selectively detected using specific 
antibodies conjugated with different fluorescence markers. The choice of 
fluorescence markers was based on the consideration that the absorption and 
emission peaks of different markers were not overlapping [I–III]. The 
illustrative scheme of the detection of the three most common mastitis-causing 
pathogens is shown in Figure 1.  
 
 
Figure 1. Scheme of multiplex biosensing of mastitis-causing pathogens using bead 
injection analysis platform. The sample is injected into the system, where pathogens are 
captured to the bio-functionalized beads. The captured pathogens are detected with 
specific antibodies conjugated with different fluorescence markers. 
 
 
3.2. Biosensor set-up 
Measurements were carried out using FIALab 3500 system (FIALab Instru-
ments). This unit, comprising a high-resolution micro-syringe pump and a 
multi-position valve (Lab-on-valve, LOV), use computer control software to 
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carry out measurements in flows and allows to optimize all steps of assay 
protocol. The FIALab unit was connected with a light source (DH-2000, Ocean 
Optics) and spectrophotometer (USB 2000+ equipped with advanced electro-
nics and extended 200 µm wide slit, Ocean Optics) to perform fluorescence 
measurements. For light transmission we used fibres with core diameter of 400 
µm. The excitation light was filtered with an adjustable bandpass linear variable 
filter (Ocean optics LVF-HL), optimized for 300–750(±5) nm wavelength 
ranges. The LOV was additionally equipped with a moving plug to assure the 
capture of the beads into appropriate channel's geometry and shielded with a 
black light-tight cover to minimize the interference of incidental light. The 
biosensor set-up and the assay scheme on LOV are shown in Figure 2.  
 
 
 
 
 
 
  
 
 
 
 
Figure 2. The biosensor set-up. Flow and light directions in measurement valve are 
shown with arrows: grey arrows show the direction of flow and beads movement; 
coloured arrows show the direction of excitation and emission light. 
 
 
3.3. Measurements 
3.3.1. Preparation of bioactivated beads and  
microcolumns for pathogens assay 
For the binding of the studied pathogens from buffer or milk samples, human 
IgG Fc fragment and/or bovine lactoferrin were immobilized onto beads to form 
capturing microcolumns.  
Human IgG was separated from the blood serum of healthy volunteers 
(donated by the Department of General and Molecular Pathology, University of 
Tartu) using affinity chromatography on protein G column, cleaved with papain 
and the Fc fragment purified on protein G column [I].  
For the immobilization of pathogen-capturing proteins, Sephadex G50 
Medium gel was first swollen in MilliQ water (1: 20 w/w) and activated with 
epichlorohydrin [I]. After that, the activated beads were incubated with IgG Fc 
fragment or bovine lactoferrin for 24 h and washed carefully to remove the 
unbound material. The only difference in the procedure of immobilizing human 
IgG Fc fragment and bovine lactoferrin were the pH values of binding buffers, 
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which were 9.5 and 13.0, respectively. Different pH values were selected 
according to different isoelectric point values of these proteins. 
The free binding sites, potentially available for non-specific adsorption, 
were blocked with ethanolamine and after thorough washing the prepared 
biospecific gel was stored in Na-phosphate buffer (PBS, 0.01 M, pH 7.2, 
0.15 M NaCl) at 4 ºC for further use. The presence of immobilized proteins on 
beads was controlled by staining the beads with Coomassie Brilliant Blue  
G-250 after bioactivation [I]. There was no significant change in binding 
activity of the gel for at least 2 months [I]. Biospecific beads were used for the 
production of microcolumns either as single agents or were mixed at different 
ratios depending on the aim of analyses. 
 
 
3.3.2. Specific detecting antibodies 
For the detection of S. aureus and E. coli commercial goat polyclonal anti-
Protein A antibody (10 mg/ml; NB120–7243) conjugated with Texas Red 
(maximal emission at λem=615 nm) and rabbit polyclonal anti-E. coli antibody 
(4.0 mg/ml; NB 100–64448) conjugated with fluorescein isothiocynate (FITC, 
λem=525 nm), respectively (all from Novus Biologicals) were used [I, II]. As 
there are no commercial anti-Str. uberis antibodies available, these particular 
antibodies were designed using bioinformatic analysis and solid phase peptide 
synthesis to mimic the adhesion protein SUAM of Str. uberis. The antibodies 
were purified from the blood antisera of immunized rabbits (obtained from 
LabAs AS) with affinity chromatography, using synthetic peptides as affinity 
ligands [III]. The purified anti-Str. uberis antibody was conjugated with 
Lightning-Link® Rapid Dylight® 550 fluorescence marker (Innova Biosciences 
Ltd, λem=576 nm) [III]. 
 
 
3.3.3. Optimization of assay parameters 
Optimal experimental conditions along with volumes of sample and analytical 
agents were found for the assay. First, to produce semiselective microcolumns 
we modified the volume of bio-activated beads from 10 to 40 µl (dry weight 1 
mg to 4 mg). To secure the homogeneity of beads suspension, the beaker was 
constantly shaken during the inflow of beads. Transport of beads to the cell was 
secured by adding 30 µl PBS at a flow rate of 2 µl/sec. After forming of the 
pathogen-capturing column, a sample was introduced at a flow rate 1–5 µl/sec. 
We commonly used a sample volume of 150 µl to achieve a detection limit 
around 10 pathogen cells per ml. For the attachment of bacteria onto column, 
the sample incubation time was dependent on the bacteria and was up to 
540 sec. The sample matrix and unbound bacteria were removed from the 
column with 700 µl PBS at the flow rate 10 µl/sec. Finally, 30 µl of secondary 
detecting antibody conjugated with a fluorescence marker was injected at flow 
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rate 1 µl/sec, incubated for 60–120 sec and the unbound antibodies were 
removed with 150 µl PBS at a flow rate 2 µl/sec. All measurements were 
carried out at room temperature [I, II].  
 
 
3.3.4. Data acquisition and analysis 
The presence of pathogens in a sample was detected by the fluorescence 
intensity of the complex of fluorescence marker conjugated detecting antibody 
and captured pathogen in a definite part of the microcolumn. FIALab 5.0 
(FIALab Instruments, Medina, WA) software was used to control the system, 
and for data collection. Depending on the aim of the analysis, the fluorescence 
signal was recorded at up to 3 different wavelengths. The biosensor signal, 
characterizing a particular sample was calculated as a difference (ΔI) of average 
signal intensity before adding the secondary antibody and after removing 
unbound secondary antibody since the signal was stabilized (Fig. 3).  
 
 
Figure 3. An example of biosensor signal intensity change during the experiment. The 
analysis was carried out at a S. aureus concentration of 4x108 CFU/ml in PBS (0.01 M, 
pH 7.2, 0.15 M NaCl).  
 
An average signal value for each pathogen concentration in the range 101–109 
CFU/ml was calculated on the basis of 3–5 identical measurements. For data 
analysis and calculation of optimal parameters for biosensor calibration, we 
used GraphPad Prism® 5 software (GraphPad Software, San Diego, CA, USA). 
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3.5. Culturing of bacteria 
 
 
3.6. Milk samples 
Milk was collected from healthy cows from the experimental farm of the 
Estonian University of Life Sciences, Tartu. Raw milk was centrifuged for 
5 min (2450 x g) to remove fat. Milk samples were diluted 1:1 (v/v) with PBS 
(0.01 M, pH 7.2, 0.15 M NaCl) and used as a negative control. For a positive 
control, PBS used for dilution contained a fixed amount of bacteria and it was 
added to milk immediately before measurements. 
Milk samples of cows suffering from acute clinical mastitis were collected 
from different farms in Estonia. The mastitis-causing pathogens in milk samples 
were at first identified with microbiological tests. Samples, where a major 
contagious pathogen was identified, were used for further analyses with the bio-
sensor. To avoid the growth of bacteria in the collected samples, the samples 
were instantly freezed at –20 ºC and melted at 4 ºC before analyzing. The pro-
cessing of the mastitis milk samples were similar to that described above for 
milk samples of healthy cows, except the added PBS contained no bacteria. 
 
  
E. coli (ATCC 25922) and S. aureus (ATCC 6538) were cultivated on blood 
agar plates in aerobic conditions for 24 h at 37 ºC. Bacterial cells were collected 
with sterile tampon, dissolved in Na-phosphate buffer solution (0.01 M, pH 6.5, 
0.15 M NaCl) and stored at 4 ºC [I, II]. 
Str. uberis (ATCC BAA-854/0140J) was cultivated on sheep blood agar plates 
in aerobic conditions at 37 ºC for 48 h. After harvesting, the bacteria were reculti-
vated in similar conditions for another 48 h. Str. uberis cells were collected, 
suspended in Na-phosphate buffer solution (0.01 M, pH 7.4, 0.15 M NaCl), 
washed twice with the same solution, centrifuged (JOUAN CR3i, 20 min, 
4000 rpm) and stored at 4 ºC [III].  
The bacterial concentrations were determined by optical density of the 
bacterial suspension at a wavelength λ=600 nm. 
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4. RESULTS AND DISCUSSION 
4.1. Optimal protocol for pathogen detection 
4.1.1. Detection of single pathogens 
The following operational parameters of the biosensing system were optimized 
[I]: 
1) Amount of bioactivated beads to form reproducible pathogen-sensitive micro-
columns. 
2) Input/output flow rates for gel, samples, washing buffer and detecting secon-
dary antibodies. 
3) Incubation times for antibody/antigen interactions. 
 
A sufficient volume of the bioactivated gel suspension to form a micro-column 
was 20 µl. This volume contained ~2 mg dry beads and formed a stable micro-
column. The reproducibility of column packing with such an amount of beads 
was very good, as no signal fluctuations exceeding background noise were 
detected in the series of 5 identical measurements [I]. The number of binding 
sites on the beads, with IgG Fc fragment or bovine lactoferrin could quan-
titatively bind pathogens with concentration up to 2×109 CFU/ml and 
4×109 CFU/ml, respectively. It was sufficient to capture interacting bacteria in 
quantitative mode even at the highest studied concentrations which were 
exceeding in case of 150 µl sample the total bacterial number in mastitis milk at 
least 10 times in the case of all common mastitis-causing bacteria [69]. 
An optimal sample volume for the measurements was 150 µl [I]. This 
volume, assuming that at least one pathogen cell is statistically present in a 
sample, theoretically allows to achieve a LOD value of 6 CFU/ml [II]. In case 
lower LOD values are required, it is possible to use bigger sample volumes, 
although this may require longer time for analysis. 
The sample input flow rates were varied in the range of 1–5 µl/sec. At flow 
rate 5 µl/sec, the maximal signal was achieved in 300 sec. The optimal input 
flow rate was 1 µl/sec, at which the maximal signal was achieved in 120 sec. To 
ensure the maximal value of the measured signal, an incubation time of 180 
seconds, corresponding to 10 half-times of the association at a flow rate of 
1 µl/sec was used for the attachment of pathogens onto the column [I]. 
High selectivity of the biosensor was achieved by dual step biosensing – the 
initial attachment of pathogens to the column (or pre-concentration) and the 
following specific antigen/antibody interaction with the bound pathogen. The 
incubation time of the detecting secondary antibody was varied from 0 to 
180 sec. It was found that the optimal incubation time for forming detectable 
antibody-antigen complex was 60 sec for S. aureus and Str. uberis and 120 sec 
for E. coli, since the fluorescence signals did not increase during longer 
incubation times [I]. 
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The background signal of the micro-column, caused by Sephadex G50 
Medium beads was 3.2±1.3 µV (~5% of maximum signal) determined at 
different wavelengths between 500 and 700 nm [I].  
To regenerate the biosensing system, the moving plug was opened and the 
flow channel was washed 3 times with 1 ml of PBS (0.01 M, pH 7.2, 0.15 M NaCl) 
(200 µl/sec), 3 times with 1 ml of 70% ethanol (200 µl/sec, ethanol was hold in 
a system for 3 min after last washing) and 2 times with 1 ml of PBS (200 µl/sec). 
After analyses of milk samples, 0.01 % Tween 20 was added to PBS used for 
washing. 
 
 
4.1.2. Multiplex pathogen detection 
For the simultaneous attachment of different pathogens onto microcolumn, a 
mix of beads functionalized with human IgG Fc fragment or bovine lactoferrin 
was used. Both S. aureus and E. coli bind to human IgG Fc fragment showing 
comparable affinity (with Kd values of 10–8 M) [89;90], whereas Str. uberis and 
S. aureus bind to bovine lactoferrin (with Kd values of 10–7 M and 10–8 M, 
respectively) [55;91]. Our experiments and the absence of data in literature 
indicated that there was no binding of Str. uberis to human IgG Fc or E. coli to 
lactoferrin (our unpublished data).  
For the multiplex detection of all studied pathogens within their presumed 
concentration range from <103 to 107 CFU/ml in mastitis milk [69], we deter-
mined the optimal ratio of differentially functionalized beads for the formation 
of micro-columns. First we calculated the number of binding sites potentially 
available on the biofunctionalized beads for the attachment of pathogens from 
150 μl sample. Assuming that binding agents form a monomolecular layer on 
the bead surface, we found that beads within 20 µl gel suspension, activated 
with human IgG Fc fragment or bovine lactoferrin, could quantitatively bind 
pathogens up to 2×109 CFU/ml [II] and 4×109 CFU/ml, respectively. This 
shows that the detection of pathogen concentrations up to 108 CFU/ml requires 
less than 10% of the specifically bioactivated beads of the total amount of the 
beads of the micro-column. As we used a two-component mixture of differently 
activated beads, the biosensor optimal working range was secured by mixing 
equal amounts of IgG Fc fragment and bovine lactoferrin functionalized gels 
and not changing the total volume of gel compared with single pathogen 
detection.  
For the multiplex detection of pathogens, we combined the optimized 
protocols for single pathogen detection and used the longest required incubation 
time, being 180 sec for the attachment of pathogens to the column and 120 sec 
for the attachment of the detecting antibodies. 
Assessing the sensitivity of the biosensor system towards different patho-
gens, we should also consider the number of antigenic determinants on the 
bacterial cell, accessible to detecting antibodies. In principle this epitope number 
is the multiplication factor of the measurable fluorescence signal, generated by 
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a single cell. It has been found that the number of protein A molecules on 
S. aureus cell outer membrane and outer membrane protein A (OmpA) 
molecules on E. coli membrane, which both interact with human IgG Fc 
fragment, is 104 and 105 respectively [II]. The number of Str. uberis adhesion 
protein molecules (SUAM) on the outer membrane of the cell, which ensure the 
binding of this pathogen to host cells and which fragment was used for the 
production of anti–Str. uberis antibodies is estimated to be 7800 [55].  
 
 
4.2. Detection of pathogens 
4.2.1. Detection of single pathogens 
Using optimized protocols [I, II] we studied the dependences of the biosensing 
system signal on single pathogen concentrations both in PBS (0.01 M, pH 7.2, 
0.15 M NaCl) and in milk matrix. The pathogen concentration range in our 
studies was chosen according to the predicted concentration of pathogens in 
mastitis milk [69]. An additional criterion was to meet the limits of allowed 
pathogen concentrations in milk. For direct marketing of raw milk and raw milk 
products the upper limit for S. aureus is 500 CFU/ml and 2000 CFU/ml, 
respectively [22]. The maximum limit for E. coli in raw milk is not officially 
established, but according to good practice is 103 CFU/ml [92]. 
S. aureus could be detected in a wide range – from 30 CFU/ml to 109 CFU/ml 
[I]. The dependence of the signal on S. aureus concentration in semi-
logarithmic scale both in PBS and in milk is shown on Figure 4.  
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Figure 4. Dependence of the signal on S. aureus concentration in PBS (0.01 M, pH 7.2, 
0.15 M NaCl,) and in milk (diluted 1:1 with PBS). The biosensor signal was calculated 
as a difference of average signal intensity ΔI before adding the secondary antibody and 
after washing unbound secondary antibody since the signal was stabilized at λ=615 nm.  
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In semi-logarithmic scale, we determined the linear working ranges for all 
studied single pathogens, although the determination of the limiting values of 
the working range was problematic, as the signal dependence obeyed expo-
nential pattern. In PBS (blue circles in Fig. 4) the linear working range was 
from 3×103 to 4×107CFU/ml and in milk spiked with S. aureus (red circles in 
Figure 4) from 4×102 and 4×107 CFU/ml. The slopes, characterizing the linear 
part of the dependence, in PBS and in milk were 5.12±0.39 µV/log(CFU/ml) 
and 5.33±0.53 µV/log(CFU/ml), respectively [I]. The slopes of the linear range 
dependence in semi-logarithmic scale were similar in PBS and in milk, although 
the absolute value of signal in milk was about 5 µV higher than that of the 
signal in PBS at similar S. aureus concentrations. Higher signal in milk 
compared to PBS can be caused by matrix effect of milk and the aggregation of 
bacteria [II]. The detection limits in PBS and in milk were 30 and 200 CFU/ml, 
respectively, calculated as the S. aureus concentration corresponding to the 
signal, exceeding the average signal in pure PBS (3.2±0.2 µV) or milk 
(6.5±1.2 µV) by the value of 3 standard deviations [I].  
For the detection of E. coli we used the biosensor system in pathogen 
concentration range from 30 to 3x106 CFU/ml in a buffer solution and in milk 
(Fig. 5) [II].  
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Figure 5. Dependence of the biosensing system signal on the E. coli concentration in 
PBS (0.01 M, pH 7.2, 0.15 M NaCl) and in milk (diluted 1:1 with PBS). The biosensor 
signal was calculated as a difference ΔI of average signal intensity before adding the 
secondary antibody and after washing unbound secondary antibody since the signal was 
stabilized at λ=525 nm.  
 
The dependence of biosensor signal on E. coli concentration in semi-loga-
rithmic scale was linear within the range 300–3×106 CFU/ml both in PBS (blue 
circles in Fig. 5) and in milk (red circles). The slope of linear part, which 
characterize the system sensitivity to E. coli, was 3.87±0.38 µV/log(CFU/ml) in 
PBS and 6.01±0.28 µV/log(CFU/ml) in milk. As already pointed out above, the 
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higher sensitivity in milk may be caused by the aggregation of bacteria, not 
occurring in buffer solution [II].  
For the detection of Str. uberis a preliminary semi-logarithmic calibration 
curve was composed within a concentration range from 10–109 CFU/ml in PBS 
and in milk (Fig. 6).  
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Figure 6. Dependence of the biosensing system signal on the Str. uberis concentration 
in PBS (0.01 M, pH 7.2, 0.15 M NaCl) and in milk (diluted 1:1 with PBS). The bio-
sensor signal was calculated as a difference ΔI of average signal intensity before adding 
the secondary antibody and after washing unbound secondary antibody since the signal 
was stabilized at λ=576 nm.  
 
The dependence of biosensor signal on Str. uberis concentration in semi-
logarithmic scale was linear within the range from 100 to 106 CFU/ml both in 
PBS (blue circles in Fig. 6) and in milk (red circles). The slope of linear part of 
the biosensor signal dependence on the concentration of Str. uberis was 6.1±0.3 
in PBS and 6.8±0.9 µV/log(CFU/ml) in milk.  
The total time of analysis for each single pathogen with the biosensor was 
approximately 17 minutes. 
 
 
4.2.2. Multiplex pathogen detection 
To study the system’s selectivity and possible interference of different 
pathogens on the biosensor signal of a particular pathogen, measurements were 
carried out in mixtures of three pathogens (S. aureus, E. coli and Str. uberis) at 
different concentration ratios. 
Based on the obtained results, calibration graphs for the detection of 
different pathogens were constructed, wherein the results were compared with 
the results in samples, containing only one single pathogen. The statistical 
analysis revealed that the presence of several pathogens in samples had no 
relevant impact on calibration parameters within pathogens’ concentration 
range 103–108 CFU/ml and the detected signals coincided within the range of 
errors [II]. These results confirm that the selectivity of the biosensing system in 
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the presence of several pathogens (even at concentrations up to 108 CFU/ml) is 
very good and it is applicable for the multiplex detection of different pathogens 
both in PBS and in milk. The micro-column formed with 20 μl of bead 
suspension, activated with human IgG Fc fragment or bovine lactoferrin, could 
quantitatively bind pathogens with concentration up to 2×109 CFU/ml [II] and 
4×109 CFU/ml, respectively. 
We also studied the possibilities to expand the linear region of the depen-
dence of biosensor signal vs pathogen concentration over the whole studied 
pathogens’ concentration range. So graphs on log (measured signal) vs log 
(pathogen concentration) scale were constructed for the determination of all 
three pathogens (Fig. 7). 
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Figure 7. The calibration curves in PBS (0.01 M, pH 7.2, 0.15 M NaCl) and in milk 
(diluted 1:1 with PBS) in log-log coordinates. A: S. aureus; B: E. coli; C: Str. uberis. 
Data of experiments carried out with a single pathogen (filled circles) and in the 
presence of other pathogens at different concentration (open circles) are combined. Each 
point is an average biosensor signal value of 3–5 identical measurements. 
 
The dependence of the biosensor signal on a particular pathogen concentration 
on Fig. 7 is characterized by the following equation [II]:  
 
 log(߂ܫ) = ܣ log[݌ܽݐℎ݋݃݁݊] + ܤ,  (1) 
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where parameter A denotes the slope and B the intercept of the calibration 
curve. From Eq. 1, the concentration of a single pathogen can be calculated as 
follows [II]: 
 
 [݌ܽݐℎ݋݃݁݊] =  10ቂౢ౥ౝ(∆಺)షಳಲ ቃ.  (2)  
 
According to Eq. 2, we calculated the value of parameters A and B for all 
studied pathogens for our biosensor set-up and used these for the determination 
of S. aureus, E. coli and Str. uberis in milk samples. The obtained values of 
these parameters for S. aureus, E. coli and Str. uberis from the combined 
experimental data in milk are shown in Table 4. 
 
Table 4. Calibration parameters for the detection of single pathogens in milk with our 
biosensor setup. 
Pathogen A value B value 
Staphylococcus aureus 0.116±0.006 0.718±0.031 
Escherichia coli 0.101±0.003 0.925±0.015 
Streptococcus uberis 0.0928±0.0169 1.25±0.06 
 
As it can be seen from Table 4, the slopes of the calibration curves for different 
pathogens using different fluorophores were quite similar meaning that the 
biosensor sensitivity (parameter A) towards different pathogens in milk was 
alike. This is a promising starting point for the development of pathogens 
biosensors for practical applications. 
The value of background signal (parameter B) for different pathogens was 
different, being the smallest for S. aureus and the largest for Str. uberis. This 
may be caused by light scattering on different wavelengths in milk caused by 
colloidal particles in milk, as well as the different dimensions of the bacterial 
cells determined. 
Due to technical problems, the total time for multiplex pathogen detection 
was 35 minutes, but the analysis time can be reduced to the same time frame as 
for single pathogen detection by using combined light for the simultaneous 
excitation of fluorescent markers at different wavelengths or a different set of 
fluorescent markers, which have similar excitation, but different emission 
wavelengths. 
 
 
4.3. Milk analysis and validation of biosensor results 
To validate the results obtained with the biosensor system and test the system’s 
applicability in real mastitis milk samples, a series of analyses were carried out, 
where unknown mastitis causing pathogens in infected cows' milk samples were 
detected and quantified both with the biosensor and microbiological cultivation.  
32 
For the detection of S. aureus in mastitis milk, blood agar, where S. aureus 
typically forms a light to golden yellow pigment colonies which are surrounded 
by zones of clear beta-hemolysis, was used [93]. Coliforms and enteric patho-
gens were detected using their ability to ferment lactose on MacConkey agar, 
where lactose-fermenting bacteria, like E. coli form red to pink colonies while 
non-lactose fermenting bacteria appear as colourless or transparent colonies 
[94]. Edward’s aesculin crystal violet blood agar was used as a selective 
medium for detecting streptococci. Aesculin-fermenting organisms like Str. 
uberis are forming black colonies; other streptococci are forming colourless 
colonies [95]. The results of microbiological analyses along with biosensor 
results for selected mastitis milk samples are shown in Table 5. 
As it can be seen from Table 5, the identification of mastitis causing 
pathogens with different methods gives well–matched results. Differences 
between results with biosensor and microbiological cultivation in case of E. coli 
are caused by that, this medium is not totally specific towards E. coli and all 
lactose-fermenting bacteria form colonies. Therefore additional biochemical 
tests are needed for the confirmation of E. coli. 
At the same time, the quantitative results obtained with different methods are 
varying. The correlation is better for samples, which contain blood and are 
curd-like than for samples, which externally look like normal milk. For these 
samples, the difference in the number of bacteria is several orders of magnitude. 
Such difference is caused by the fact that using different methods, the bacterial 
abundance is determined differently: biosensor detects reproductive as well as 
viable but nonreproductive and dead bacteria; while with microbiological 
cultivation it is possible to detect only reproductive bacteria. The other reason 
for different quantitative results can be the collection of samples, as in this 
study the farmers collected the samples theirselves and some milk samples were 
probably collected from cows whose treatment with antibiotics had been 
already started. So there may be many dead bacteria in milk, which also could 
cause overestimation of the number of bacteria in a sample with biosensor. For 
the implementation of cut-off values for pathogen concentrations in mastitis 
milk and the development of biosensor based diagnostic tests for the 
identification of animals suffering from different forms of infection, further 
studies should be performed to study the correlation of results obtained with 
different methods.  
One mastitis causing pathogen was found in only two of the studied 17 
samples, while in other samples there were two or more different pathogens. 
According to current practice, the simultaneous presence of two or more 
bacterial species in milk is considered to be a sample contamination during 
collection. On the other hand, there are references in the literature [69] that 
mastitis can be caused by several pathogens at the same time. Thus, the 
biosensor results can give additional information about the presence and 
concentration of several pathogens and help to modify the schemes of animal 
treatment, which are currently focused only on the main mastitis-causing 
pathogen. 
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Table 5. Concentrations of S. aureus, E. coli and Str. uberis in mastitis milk samples, determined with 
biosensing system and microbiological cultivation (pictures of representative samples). 
 Staphylococcus aureus, 
CFU/ml 
Escherichia coli, 
CFU/ml
Streptococcus uberis, 
CFU/ml
Descrip-
tion of the 
milk sampleBio-
sensor* 
Hemolytic 
colonies on 
blood agar** 
Bio-
sensor*
Pink colonies 
on MacConkey 
agar**/*** 
Bio-
sensor*
Black colonies 
on Edwards 
agar** 
1 
 
3.8×106 5.04×105 
 
103 4.9×102 103 80 
 
Medium fat 
consistence, 
like a 
normal milk 
2 – – – 1.4×103 5.4×105 7.6×103 
 
Bloody, 
curdlike, 
low fat 
consistence 
3 8.6×106 5.12×105 
 
102 3.36×103 105 2.76×103 
 
High fat 
consistence, 
flaky 
4 90 0 – 1.8×102 3.9×105 0 High fat 
consistence, 
like a 
normal milk 
5 – 0 4,7×102 2,4×103 – 0 Very low fat 
consistence, 
lumpy 
*– An average concentration of 3–5 measurements 
**– Determined from the results of three different sample dilutions (nondiluted; 10×; 100×) 
***– Total quantity of lactose-fermenting bacteria 
– – Under the limit of detection  
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CONCLUSIONS 
As a result of these doctoral theses, a novel method and an immuno-biosensing 
system have been developed and applied for the rapid multiplex detection of 
major mastitis causing pathogens in milk. 
The key features of the biosensor development were its selectivity, 
sensitivity, working range and applicability for rapid automated analyses in 
complex biological sample matrix like milk.  
To carry out the analyses, pathogens were first concentrated by semispecific 
capturing onto single-use renewable micro-columns and then specific 
antigen/antibody interaction was used for the detection of individual pathogens. 
Specific antibodies conjugated with different fluorescence markers of non-
overlapping emission maximums are required to identify different pathogens at 
the same time. We used commercial fluorophore labelled antibodies for the 
detection of S. aureus and E. coli. As no anti-Str. uberis antibodies are commer-
cially available, these particular antibodies were designed using bioinformatic 
analysis to mimic the antigenic regions of adhesion protein SUAM, exhibited 
on Str. uberis membrane. The antibody production was ordered by immunizing 
rabbits with the conjugates of the selected antigenic peptides, which were 
synthesized in solid phase. The monospecific anti-Str. uberis antibodies were 
purified from the blood antisera using affinity chromatography, and conjugated 
with Dylight 550 marker for their application in Str. uberis immunosensor. In 
our biosensor, S. aureus was detected at wavelength λ=615 nm, E. coli at 
λ=525 nm and Str. uberis at λ=576 nm. 
Optimal experimental conditions for single as well as for multiplex pathogen 
detection were found by varying sample volume, incubation time, etc. Using 
these optimized protocols, the dependences of the signal of the biosensing 
system on three major mastitis-causing pathogens (S. aureus, E. coli and Str. 
uberis) concentrations were studied both in buffer and in milk matrix. The 
biosensor signal was a bit higher in milk than in buffer in case of all studied 
pathogens. 
The system’s selectivity and possible interference of different pathogens on 
biosensor signal was also studied. The obtained results confirmed that there was 
no cross-reactivity in the presence of other bacteria at their concentrations up to 
108 CFU/ml, confirming the applicability of the biosensor for the multiplex 
detection of different pathogens.  
The linear region of the biosensing system’s working range was con-
siderably extended by using logarithmic scale for the construction of calibration 
curves. Our biosensor calibration parameters for this model were calculated for 
all studied pathogens and used for the determination of these pathogens in milk 
samples. For the validation of the results obtained with our immuno-biosensing 
system and testing the system’s applicability in real mastitis milk, a series of 
analyses were carried out, where unknown mastitis causing pathogens in the 
milk of infected cows were detected and quantified both with the biosensor and 
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microbiological cultivation. The identification of mastitis causing pathogens 
with different methods gave well–matched results, although, further studies are 
required to understand the correlation between quantitative results, which were 
obtained with different methods. Establishment of such correlations allows to 
define the cut-off values of pathogen concentrations in milk for the detection of 
potential infections and form a solid base to carry out automated monitoring of 
the health of cows and identification of animals suffering from subclinic or 
clinic mastitis in early stage of infection. Early identification of infected 
animals allows timely start of their accurate treatment, improving the welfare of 
animals. The biosensor results can give valuable information about the presence 
and concentrations of several pathogens and help to modify animal treatment 
schemes, which are currently focused on the major single mastitis-causing 
pathogen. The application of pathogen biosensors also allows to reduce 
production costs and improve the quality of raw milk and dairy products. Based 
on the results of the present study, the proposed biosensing system has a great 
potential to serve as a tool for in-line automatic monitoring of milk and animal 
health in dairy farms. 
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SUMMARY IN ESTONIAN 
Biosensorsüsteem mastiiti põhjustavate bakterite kiireks ja 
samaaegseks määramiseks piimas 
Käesoleva doktoritöö eesmärgiks oli välja töötada biosensorsüsteem peamiste 
mastiiti tekitavate patogeenide (Staphylococcus aureus, Escherichia coli ja 
Streptococcus uberis) kiireks samaaegseks määramiseks piimas. Metoodika 
põhineb spetsiifilise antigeen/antikeha bioäratundmissüsteemi kasutamisel 
kombineerituna poolspetsiifilise graanulsisestusanalüüsiga kolme erineva pato-
geeni määramiseks [I–III]. 
Mastiit on udarapõletik, mis enamasti tekib patogeensete mikroorganismide 
sattumisel läbi nisajuha udaraveerandisse, olles peamine lüpsilehmade nakkus-
haigus. Mastiidi poolt põhjustatud kahju kogu maailma 271 miljoni piimalehma 
kohta on hinnanguliselt 16–26 miljardit eurot aastas. Suur majanduslik kahju on 
põhjustatud haigestunud loomade piimatoodangu ja selle kvaliteedi vähene-
misest, suurenenud kulutustest diagnostikale ja veterinaarravimitele, ravimi-
jääkidega piima utiliseerimise vajadusest ning enneaegsest loomade väljapraaki-
misest. Hinnanguliselt kannatab 1/3 kogu maailma lüpsilehmadest vähemalt 
kord aastas mastiidi all.  
Kliinilise avaldumise järgi jaotatakse udarapõletikke kliinilisteks ja sub-
kliinilisteks. Kliinilise mastiidi avastamine toimub väliste haigustunnuste alusel; 
samuti on täheldatavad muutused piimas, mis on tükiline, kohupiimataoline 
ning võib sisaldada verd. Subkliinilise mastiidi korral loomal nähtavad haigus-
tunnused puuduvad, kuid piimas on suurenenud põletikuindikaatorite sisaldus. 
Kõige hõlpsamini määratavaks põletikuindikaatoriks käesoleval ajal on 
somaatiliste rakkude arv (SRA), mis aga ei anna infot haigustekitaja kohta.  
Traditsiooniliste meetoditena mastiiti tekitavate bakterite identifitseeri-
miseks on tänapäeval kasutusel mikrobioloogilised analüüsid, mis võtavad aega 
1–2 päeva ja laboratoorsetes tingimustes tehtavad patogeenide geenianalüüsid, 
mille tegemiseks kulub peale proovide laborisse jõudmist ligikaudu 6 tundi. 
Kuna ravi edukuse tagamiseks on selle täpsuse kõrval väga oluline ka selle 
võimalikult operatiivne alustamine, siis on vajalik välja töötada sellised ana-
lüüsimeetodid, mis võimaldavad patogeenide identifitseerimist oluliselt kiire-
mini kui praegu ning mida on võimalik kasutada farmides kohapeal. Tänasel 
päeval sellised meetodid puuduvad. 
Üheks võimalikuks alternatiiviks traditsioonilistele kasutusel olevatele 
meetoditele on biosensorite kasutamine. Biosensorite eeliseks on lihtsus, lühike 
analüüsi aeg ja odavus ning nende sobivus kohapealseks analüüsiks. Selle 
metoodika puhul jääb ära aeganõudev proovide eeltöötlus. 
Doktoritöö käigus töötati välja biosensorsüsteem ja mõõtemetoodika kolme 
peamise mastiiti tekitava patogeeni – Staphylococcus aureus’e Escherichia coli 
ja Streptococcus uberis’e määramiseks nii eraldi kui ühtlasi ka kõikide nime-
tatud patogeenide koos määramiseks. Biosensorsüsteemi konstrueerimisel uuriti 
selle tundlikkust, tööpiirkonda, selektiivsust ja sobivust rakendamiseks keeru-
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listes maatriksites nagu piim. Erinevate bakterite üheaegse määramisesüsteem 
põhineb mitmel etapil: esmalt kogutakse patogeenid poolspetsiifiliste graanu-
litega, seejärel kasutatakse igale mikroorganismile selektiivset antikeha, 
kusjuures erinevad antikehad on seotud erineva luminestsentsmarkeriga, mille 
neeldumis- ja kiirgusspektrid ei kattu, mis seega võimaldab baktereid sama-
aegselt määrata [I–III]. 
S. aureuse ja E. coli vastased antikehad koos vastavate fluorestentsmarke-
ritega on kommertsiaalselt saadaval, kuid ei ole müügil antikehasid S. uberise 
vastu. Seetõttu S. uberise vastased antikehad toodeti, eraldati ja puhastati 
immuniseeritud küülikute vereseerumist, märgistati need luminestsentsmarke-
riga ning kasutati saadud antikehasid S. uberise määramiseks biosensor-
süsteemis [III].  
Töö tulemusena leiti optimaalsed eksperimentaalsed tingimused nagu proovi 
suurus, voolu kiirus, inkubatsiooni aeg kõigi bakterite jaoks. Mitme bakteri 
samaaegsel määramisest lähtuti “halvimast” tulemusest [I, II]. Kasutades neid 
optimeeritud protokolle leiti biosensorsüsteemi signaali sõltuvused erinevate 
bakterite kontsentratsioonidest nii puhvrilahuses kui ka piimas. Antud lähene-
mine võimaldas antud bakterid identifitseerida ja kvalifitseerida vahemikus 10–
108 CFU/ml. Piimas oli foon kõrgem, kuid see ei takistanud määramist. Oluline 
on, et kõiki baktereid on võimalik kvantifitseerida kuni 108 CFU/ml ka teiste 
bakterite juuresolekul. 
Uuritud biosensorsüsteemide lineaarne tööpiirkond kõikide patogeenide 
puhul oli sobilik biosensori kasutamiseks reaalsetes piimaproovides [I, II]. 
Biosensori selektiivsus kindla patogeeni määramiseks teiste bakterite 
olemasolul (kuni kontsentratsioonini 108 CFU/ml) oli väga hea ning seda on 
võimalik kasutada mitme bakteri samaaegseks määramiseks [II]. Kõigi uuritud 
bakterite jaoks leiti biosensori kalibreerimisparameetrid, mis on aluseks bio-
sensorite edaspidisele kasutamisele mastiiti põhjustavate bakterite määramiseks 
piimas. 
Väljatöötatud biosensorsüsteemi testimiseks ja saadavate tulemuste usaldata-
vuse hindamiseks analüüsiti mastiiti haigestunud lehmade piimaproove kolme 
uuritud patogeeni sisalduse suhtes nii biosensoriga kui ka mikrobioloogiliste 
külvide abil. Tulemuste võrdlemisel selgus, et bakterite identifitseerimisel oli 
tulemuste kokkulangevus väga hea. Tulemuste erinevusi oli patogeenide 
kontsentratsiooni määramisel, mis tuleneb sellest, et erinevalt mikrobioloogi-
lisest analüüsist määratakse biosensoriga lisaks kasvuvõimelistele patogeenidele 
ka nn „uinuvaid” ja surnud baktereid. Samuti oli erinevus kahe meetodi 
vahel E. coli määramisel, mis tulenes sellest, et konkreetne külv ei ole selek-
tiivne E. coli suhtes. Erinevatel meetoditel saadud kvantitatiivsete tulemuste 
korrelatsioonide leidmine on edasiste uuringute oluline eesmärk, et defineerida 
haigestumist näitavad patogeenide kontsentratsioonid ning töötada välja alused 
loomade tervise automaatseks monitoorimiseks. Kuna käesoleval ajal identifit-
seeritakse piimaproovides tavaliselt ainult üks peamine mastiiti tekitav pato-
geen, siis biosensoriga saadavad tulemused annaksid edaspidi võimaluse 
loomade raviskeemide modifitseerimiseks ning täpsustamiseks. Väljapakutud 
44 
biosensorsüsteemil põhinevat mõõtesüsteemi on võimalik kasutada loomade 
tervise automatiseeritud kontrolliks farmis kohapeal ja seeläbi kiiresti identifit-
seerida juba varajases staadiumis potentsiaalne haigus. Varajane haiguse avasta-
mine aitab alustada koheselt kiiret ja sobivat ravi, parandades seeläbi looma 
heaolu ja piima kvaliteeti ning vähendada tootmiskulusid ja majanduslikku 
kahju aga vähendab ka ravimijääkide sattumist loodusesse. 
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